What is the RPG Life Sciences Ltd share price today?

The share price of NSE:RPGLIFE-EQ on 01 Oct 2026 (as of 15:04:44 IST) is ₹2919.

What is the NSE:RPGLIFE-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:RPGLIFE-EQ 52 week high low range shows a high of ₹3127.8 and a low of ₹1733.

What is the RPG Life Sciences Ltd market cap?

As on 01 Oct 2026, RPG Life Sciences Ltd market cap is ₹50218200000.

What is the shareholding pattern of RPG Life Sciences Ltd Stock?

The shareholding pattern of RPG Life Sciences Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 72.95% Foreign Institutional Investors (FII): 0.95% Domestic Institutional Investors (DII): 6.62% Mutual Funds: 0.04% Retail & Others: 19.44% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of RPG Life Sciences Ltd?

The Price-to-Earnings (PE) ratio of RPG Life Sciences Ltd is 43.6036, and the Price-to-Book (PB) ratio is 5.0544, as on 01 Oct 2026.

RPG Life Sciences Share Price

2529.60-19.90 (-0.78%)

+5.23% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

-0.78%

1 Week

-15.79%

1 Month

-13.69%

3 Month

-6.58%

6 Month

+1.51%

YTD

+8.93%

1 Year

+5.23%

5 Year

+256.48%

10 Year

+425.14%

Max

+4116.00%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

2520.00

2480.00

2065.30

1733.00

High

2591.00

2849.60

3050.00

3127.80

About

RPG Life Sciences a part of RPG Enterprises is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations Global Generics and Synthetic APIs space. Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

RPGLIFENSE

LTP

1W Low

1W High

Market cap (₹)

1769.9+8.9 (0.51%)

1722

1855

4,24,202Cr

10064+400 (4.14%)

9621.50

10064

2,64,141Cr

4650+70 (1.53%)

4532

4675

1,74,402Cr

2323+79 (3.52%)

2206.10

2441.90

1,26,811Cr

1240.6+56.2 (4.75%)

1182

1254.20

1,23,685Cr

1368.3+23.3 (1.73%)

1336.70

1368.30

1,11,868Cr

1396.9+38.9 (2.86%)

1357

1396.90

1,11,650Cr

2475+5.7 (0.23%)

2457.90

2528

1,02,196Cr

1694.5+34.6 (2.08%)

1647.20

1697.40

96,951Cr

2015.9+26 (1.31%)

1974

2033.80

91,301Cr

2525-478.8 (-15.94%)

2480

2849.60

4,214Cr

RPG Life Sciences Share Price

2529.60-19.90 (-0.78%)

+5.23% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year8%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year-37%

Stock Price CAGR

10 years18%

5 years29%

3 years19%

1 year4%

Return on Equity

10 years27%

5 years27%

3 years27%

Last year20%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	8%
-	-	-	-37%
18%	29%	19%	4%
27%	27%	27%	20%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

RPGLIFE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
2,525	₹4214 Cr	38.53	16.08	80.54	₹115 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
₹212 Cr	₹196 Cr	₹177 Cr	₹180 Cr	₹182 Cr	₹169 Cr	₹143 Cr	₹173 Cr
₹4 Cr	₹5 Cr	₹12 Cr	₹3 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹3 Cr
₹216 Cr	₹200 Cr	₹189 Cr	₹183 Cr	₹186 Cr	₹174 Cr	₹148 Cr	₹176 Cr
₹178 Cr	₹158 Cr	₹150 Cr	₹146 Cr	₹148 Cr	₹139 Cr	₹123 Cr	₹129 Cr
₹45 Cr	₹48 Cr	₹45 Cr	₹43 Cr	₹44 Cr	₹41 Cr	₹31 Cr	₹52 Cr
₹84 L	₹63 L	₹39 L	₹25 L	₹12 L	₹13 L	₹18 L	₹12 L
₹37 Cr	₹41 Cr	₹40 Cr	₹29 Cr	₹49 Cr	₹35 Cr	₹135 Cr	₹47 Cr
₹28 Cr	₹31 Cr	₹30 Cr	₹22 Cr	₹37 Cr	₹26 Cr	₹117 Cr	₹35 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025
—	—
₹13 Cr	₹13 Cr
₹592 Cr	₹517 Cr
₹592 Cr	₹517 Cr
₹605 Cr	₹531 Cr
₹13 Cr	₹0
₹3 Cr	-₹1 Cr
₹3 Cr	₹3 Cr
₹7 Cr	₹5 Cr
₹27 Cr	₹6 Cr
—	—
₹97 Cr	₹79 Cr
₹33 Cr	₹24 Cr
₹30 Cr	₹16 Cr
₹161 Cr	₹120 Cr
₹793 Cr	₹657 Cr
₹18 Cr	₹14 Cr
₹20 Cr	₹0
—	—
₹321 Cr	₹276 Cr
₹125 Cr	₹104 Cr
₹197 Cr	₹172 Cr
₹20 Cr	₹4 Cr
₹1 Cr	₹1 Cr
₹1 Cr	₹1 Cr
₹13 Cr	₹3 Cr
₹234 Cr	₹192 Cr
—	—
₹84 Cr	₹126 Cr
₹124 Cr	₹93 Cr
₹117 Cr	₹87 Cr
₹192 Cr	₹140 Cr
₹16 Cr	₹10 Cr
₹28 Cr	₹10 Cr
₹559 Cr	₹465 Cr
₹399 Cr	₹345 Cr
₹793 Cr	₹657 Cr
₹366	₹321
₹366	₹321

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025
₹154 Cr	₹233 Cr
-₹17 Cr	-₹76 Cr
-₹43 Cr	-₹26 Cr
₹94 Cr	₹131 Cr
₹57 Cr	₹78 Cr
₹86 Cr	-₹42 Cr
-₹21 Cr	-₹27 Cr
₹122 Cr	₹9 Cr
₹29 Cr	₹20 Cr
₹150 Cr	₹29 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

RPG Life Sciences Share Price

2529.60-19.90 (-0.78%)

+5.23% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

RPG Life Sciences Share Price

2529.60-19.90 (-0.78%)

+5.23% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 4

Bearish signals: 5 out of 9 oscillators

RSI

40.16Sell

STOCH %K

8.70Buy

MACD Level(12,26)

-47.77Sell

Ultimate Oscillator

50.37Buy

Aroon Oscillator

-48.00Sell

BOP

-0.82Sell

CCI

-181.15Buy

Williams %R

-91.30Buy

Momentum

-277.00Sell

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 2

Bearish signals: 7 out of 9 moving averages

EMA 9

2699.29Sell

SMA 9

2722.24Sell

EMA 21

2763.76Sell

SMA 21

2790.54Sell

EMA 50

2762.95Sell

SMA 50

2773.03Sell

EMA 200

2519.35Buy

SMA 200

2376.09Buy

WMA 20

2749.51Sell

Pivot

Classic

Resistance 5

2901.40

Resistance 4

2809.50

Resistance 3

2717.60

Resistance 2

2625.70

Resistance 1

2587.60

Pivot

2533.80

Support 1

2495.70

Support 2

2441.90

Support 3

2350.00

Support 4

2258.10

Support 5

2166.20

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

2520.00

2480.00

2065.30

1733.00

1292.00

450.55

142.95

15.25

High

2591.00

2849.60

3050.00

3127.80

Returns

-19.90

-474.20

-401.10

-178.20

+37.60

+207.30

+125.70

+1079.35

+1820.00

+2047.90

+2469.60

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

RPG Life Sciences Share Price

2529.60-19.90 (-0.78%)

+5.23% past 1 Year

Shareholding summary

Promoters

72.95%

FII

0.87%

DII

7.87%

MF

0.04%

Others

18.27%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
72.95%	72.95%	72.95%	72.95%	72.95%	72.95%
0.87%	0.95%	0.87%	1.00%	1.11%	1.35%
7.87%	6.62%	5.39%	4.98%	1.48%	1.09%
0.04%	0.04%	0.04%	0.04%	3.20%	3.38%
18.27%	19.44%	20.75%	21.03%	21.26%	21.23%

Bulk & block deals

Name

Nk Securities Research Private Limited

Xtx Markets Llp

Authum Investment & Infrastructure Limited

M/S Mentor Capital Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
30 Apr 2026	Purchase	24.78 Cr	₹2,257.02	1.10 L	Bulk	0.663891	NSE
30 Apr 2026	Sell	24.80 Cr	₹2,258.73	1.10 L	Bulk	0.663891	NSE
21 Sep 2021	Sell	10.02 Cr	₹731.47	1.37 L	Bulk	0.827916	NSE
21 Sep 2021	Purchase	9.91 Cr	₹730.53	1.36 L	Bulk	0.820533	NSE
03 Sep 2021	Purchase	5.34 Cr	₹596	89.62 K	Bulk	0.541895	NSE
03 Sep 2021	Sell	5.11 Cr	₹597.08	85.61 K	Bulk	0.517643	NSE
01 Sep 2021	Sell	9.09 Cr	₹568.09	1.60 L	Bulk	0.967247	NSE
01 Sep 2021	Purchase	9.20 Cr	₹566.91	1.62 L	Bulk	0.981456	NSE
06 Jan 2020	Purchase	9.64 Cr	₹294.31	3.28 L	Bulk	1.980676	NSE
06 Jan 2020	Sell	9.64 Cr	₹294.31	3.28 L	Bulk	1.980676	NSE

Insider trading & SAST

Client name

Clarus Capital I

Nucleus Life Trust (Revised)

Nucleus Life Trust

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
22 May 2026	Other	Acquisition	0.88	5.41	0	—	1.45 L	17 Apr 2026	Market	8,94,847	SAST	29(1)	—
12 Mar 2025	Promoter Group	Acquisition	0.026676	53.84	97.38 L	₹2,207.19	4.41 K	29 Nov 2024	Market Purchase	89,04,393	Insider Trading	—	Equity Shares
12 Mar 2025	Promoter Group	Acquisition	0.00185	53.81	6.38 L	₹2,085.73	306	28 Nov 2024 - 29 Nov 2024	Market Purchase	88,99,981	Insider Trading	—	Equity Shares
12 Mar 2025	Promoter Group	Acquisition	0.018429	53.86	66.69 L	₹2,187.95	3.05 K	29 Nov 2024	Market Purchase	89,07,441	Insider Trading	—	Equity Shares
12 Mar 2025	Promoter Group	Acquisition	0.01124	53.81	39.04 L	₹2,100.20	1.86 K	28 Nov 2024 - 29 Nov 2024	Market Purchase	88,99,675	Insider Trading	—	Equity Shares
26 Dec 2024	Promoter Group	Acquisition	0.010883	53.94	39.37 L	₹2,187.36	1.80 K	24 Dec 2024	Market Purchase	89,20,831	Insider Trading	—	Equity Shares
24 Dec 2024	Promoter Group	Acquisition	0.00006	53.93	21.70 K	₹2,170	10	23 Dec 2024	Market Purchase	89,19,031	Insider Trading	—	Equity Shares
24 Dec 2024	Promoter Group	Acquisition	0.005284	53.93	19 L	₹2,174.22	874	23 Dec 2024	Market Purchase	89,19,021	Insider Trading	—	Equity Shares
24 Dec 2024	Promoter Group	Acquisition	0.012165	53.92	44.17 L	₹2,195.38	2.01 K	20 Dec 2024	Market Purchase	89,18,137	Insider Trading	—	Equity Shares
24 Dec 2024	Promoter Group	Acquisition	0.00006	53.92	21.96 K	₹2,196	10	20 Dec 2024	Market Purchase	89,18,147	Insider Trading	—	Equity Shares

RPG Life Sciences Share Price

2529.60-19.90 (-0.78%)

+5.23% past 1 Year

RPG Life Sciences a part of RPG Enterprises is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations Global Generics and Synthetic APIs space.

Corporate Actions

Date

Type

Details

2026-07-09

Dividend

24.0

2025-06-27

Dividend

4.0

2025-06-27

Dividend

20.0

2024-06-28

Dividend

16.0

2023-07-21

Dividend

12.0

2022-07-14

Dividend

9.6

2021-08-13

Dividend

7.2

2020-03-24

Dividend

4.0

2019-07-22

Dividend

2.4

2018-07-19

Dividend

2.4

2017-07-13

Dividend

2.8

2016-03-22

Dividend

1.6

2015-07-20

Dividend

0.8

2014-09-11

Dividend

2.0

2013-07-11

Dividend

1.2

2012-07-24

Dividend

0.8

2011-07-14

Dividend

1.6

2010-07-15

Dividend

1.44

Company details

Registered office

R P G House , 463 Ceat Mahal Dr. Annie Besant Road, Worli Mumbai Maharashtra PIN: 400030 Tel No: 022 - 24981650 / 24986375 Fax No: 022 - 24970127 Email: [email protected] Internet: www.rpglifesciences.com

Registrars

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/

Management

Harsh Goenka, Chairman

Ashok Nair, Managing Director

Hiten Kotak, Non Executive Independent Director

Bhaskar Iyer, Non Executive Independent Director

Anil Matai, Non Executive Independent Director

Radhika Gupta, Non Executive Independent Director

Sachin Nandgaonkar, Non Executive Independent Director

Vasundhara Patni, Non Executive Director

Manoj K Maheshwari, Non Executive Director

Yugal Sikri, Non Independent & Non Executive Director

Rajesh Shirambekar, Head - Legal, Company Secretary & Compliance Officer